Endothelial progenitor cells in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Regulatory mechanisms of cell activation, renewal and recruitment Year: 2008
Evaluation of dendritic cell population in chronic obstructive pulmonary disease Source: Annual Congress 2012 - The smoking gun in COPD biology Year: 2012
Circulating tumor cells in chronic obstructive pulmonary disease patients Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer Year: 2011
Circulating endothelial progenitor cells and chronic pulmonary diseases Source: Eur Respir J 2011; 37: 426 Year: 2011
Accumulation of dendritic cells in small airways of patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis Year: 2007
Characterization of in vitro differentiated bronchial epithelial cells obtained from patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 99s Year: 2004
Efficacy of lasolvan in the treatment of patients with chronic obstructive pulmonary disease Source: Annual Congress 2009 - Drug effects in COPD Year: 2009
Inferon efficacy in the treatment of chronic obstructive pulmonary disease Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008
Targeted therapy in eosinophilic chronic obstructive pulmonary disease Source: ERJ Open Res, 7 (2) 00437-2020; 10.1183/23120541.00437-2020 Year: 2021
Pulmonary rehabilitation in interstitial lung diseases compared with chronic obstructive pulmonary disease Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019
Prognosis after severe chronic obstructive pulmonary disease exacerbation treated with non invasive ventilation Source: Annual Congress 2009 - New trends in noninvasive ventilation for acute respiratory failure Year: 2009
Angiogenic status in patients with chronic obstructive pulmonary disease. Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020
Principles of diuretic therapy of oedema syndrome in chronic obstructive pulmonary disease patients Source: Eur Respir J 2006; 28: Suppl. 50, 626s Year: 2006
Pulmonary myeloid dendritic cell numbers, phenotype and response to lipopolysaccharide in patients with chronic obstructive pulmonary disease Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation Year: 2010
Inferon administration to patients with chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation Year: 2009
Improvement of diagnosis and treatment of obstructive lung diseases with a one stop diagnostic consultancy Source: Annual Congress 2006 - COPD – the challenges for primary care Year: 2006
Variability in expression of aquoporine 1 in chronic obstructive pulmonary disease and interstitial lung disease patients Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009
Systemic inflammation and increased arterial stiffness in patients with chronic obstructive pulmonary disease Source: Annual Congress 2006 - COPD and inflammation Year: 2006
Endothelial progenitor cells and pulmonary vascular remodeling in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 435s Year: 2004
Endothelial dysfunction in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011